Stories That Empower Mothers and Postpartum Depression
Launched by EGE UNIVERSITY · Jan 18, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to help first-time pregnant women reduce their risk of developing postpartum depression, a condition that can happen after giving birth. The researchers have created a program called 'Stories to Empower Mothers,' which includes six online sessions designed to help women understand their feelings, find support, and develop coping strategies. By participating, women will not only learn about themselves but also create a storybook that captures their journey through these sessions.
To be eligible for this study, women must be in their first pregnancy, between 24 and 32 weeks along, and not experiencing any significant health issues. They should have regular doctor visits and access to a smartphone or computer with internet. Participants will complete surveys before the program starts, after five weeks, and again a few weeks after giving birth to track their mental well-being. This research is important for understanding and preventing postpartum depression, and it has received ethical approval to ensure the safety and well-being of all participants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • First pregnancy,
- • Singleton pregnancy,
- • Gestational week between 24-32,
- • Regular doctor follow-up,
- • Scored ≥ 10 on the EDBS,
- • Scored \< 17 on the BDI,
- • Literate,
- • No disability in sensory organs that would prevent communication,
- • Owning a smart phone or computer,
- • Having internet access,
- • Volunteering
- Exclusion Criteria:
- • Being in the first trimester of pregnancy,
- • Being treated/therapized with any psychiatric diagnosis,
- • Having a risky pregnancy,
- • Being at risk of premature birth and developing it,
- • Having any complications related to pregnancy (gestational diabetes, hypertension, bleeding, etc.),
- • The baby is not healthy,
- • Developing complications during and after birth,
- • The baby needs intensive care after birth,
- • Having a baby lost,
- • Having a premature birth (\<37 weeks),
- • The mother has experienced serious daily life difficulties (disaster, loss, etc.),
- • Not attending three or more of the six sessions
About Ege University
Ege University, a prestigious institution located in Izmir, Turkey, is renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, Ege University leverages its extensive academic resources and expertise in various healthcare fields to facilitate innovative clinical studies. The university is dedicated to enhancing patient care through rigorous research methodologies and collaboration with multidisciplinary teams, ensuring the development of effective therapies and interventions. With a strong focus on ethical standards and regulatory compliance, Ege University aims to contribute significantly to the global medical community by fostering groundbreaking discoveries and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, Bornova, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported